BBNX

SEC source: 0002048497-26-000018 · primarydocument.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,109

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.

F2 · price: The weighted average sale price for the transaction reported was $18.96 and the range of prices were between $18.96 and $19.9599. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048467-26-000007 · form4-09232026_090948.xml · nonDerivative · entry 1

Jones Christy · CIK 0002048467 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,564

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.

SEC source: 0002048500-26-000013 · form4-09172026_040904.xml · nonDerivative · entry 1

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,390

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.

SEC source: 0002048497-26-000015 · form4-09172026_040905.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,479

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.

F2 · price: The weighted average sale price for the transaction reported was $20.1319 and the range of prices were between $20.00 and $20.64. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048497-26-000014 · form4-09152026_040906.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,382

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.

SEC source: 0002048497-26-000016 · form4a-09182026_110936.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,033

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026 (the "10b5-1 Plan").

F2 · shares: On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares.

F2 · balance_after: On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares.

SEC source: 0002048497-26-000013 · form4-09102026_040903.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,157

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.

SEC source: 0002048593-26-000010 · form4-09042026_090921.xml · nonDerivative · entry 1

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 398,429

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 5, 2025.

F2 · price: The weighted average sale price for the transaction reported was $20.0778 and the range of prices were between $20.00 and $20.1696. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048593-26-000009 · form4-09032026_060901.xml · nonDerivative · entry 1

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 404,070

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002051384-26-000009 · form4-09032026_060906.xml · nonDerivative · entry 1

Russell Steven Jon · CIK 0002051384 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,628

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048497-26-000012 · form4-09032026_060908.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,027

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048588-26-000013 · form4-09032026_060903.xml · nonDerivative · entry 1

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,378

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048500-26-000012 · form4-09032026_060904.xml · nonDerivative · entry 1

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,040

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048588-26-000009 · form4-06302026_080605.xml · derivative · entry 6

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,817

Underlying: Common Stock · 4,896 shares

Expires 2033-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

SEC source: 0002048588-26-000009 · form4-06302026_080605.xml · nonDerivative · entry 4

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,931

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.

F3 · price: The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048588-26-000009 · form4-06302026_080605.xml · nonDerivative · entry 3

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,827

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002048588-26-000010 · form4a-07022026_100725.xml · derivative · entry 6

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,695

Underlying: Common Stock · 4,896 shares

Expires 2033-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

F1 · balance_after: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

SEC source: 0002048588-26-000010 · form4a-07022026_100725.xml · nonDerivative · entry 4

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 166,053

F2 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.

F4 · price: The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F1 · balance_after: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

SEC source: 0002048588-26-000010 · form4a-07022026_100725.xml · nonDerivative · entry 3

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

SEC source: 0002048588-26-000009 · form4-06302026_080605.xml · derivative · entry 5

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,713

Underlying: Common Stock · 4,982 shares

Expires 2033-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

SEC source: 0002048588-26-000009 · form4-06302026_080605.xml · nonDerivative · entry 2

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,931

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.

F2 · price: The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048588-26-000009 · form4-06302026_080605.xml · nonDerivative · entry 1

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002048588-26-000010 · form4a-07022026_100725.xml · derivative · entry 5

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,591

Underlying: Common Stock · 5,104 shares

Expires 2033-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

F5 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

F1 · derivative.underlying_shares: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

F1 · balance_after: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

SEC source: 0002048588-26-000010 · form4a-07022026_100725.xml · nonDerivative · entry 2

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 166,053

F2 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.

F3 · price: The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F1 · balance_after: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

SEC source: 0002048588-26-000010 · form4a-07022026_100725.xml · nonDerivative · entry 1

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

F1 · balance_after: This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.

SEC source: 0002048497-26-000009 · form4-06252026_080606.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,354

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.

F2 · price: The weighted average sale price for the transaction reported was $15.0083 and the range of prices were between $15.00 and $15.015. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048467-26-000005 · form4-06252026_080626.xml · nonDerivative · entry 1

Jones Christy · CIK 0002048467 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,994

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.

SEC source: 0002048497-26-000008 · form4-06052026_060603.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,612

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.

SEC source: 0002048467-26-000004 · form4-06052026_060601.xml · nonDerivative · entry 1

Jones Christy · CIK 0002048467 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,400

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.

SEC source: 0002051384-26-000006 · form4-06032026_060605.xml · nonDerivative · entry 1

Russell Steven Jon · CIK 0002051384 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,849

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048500-26-000009 · form4-06032026_100646.xml · nonDerivative · entry 1

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,415

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048497-26-000007 · form4-06032026_060607.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,887

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048588-26-000008 · form4-06032026_060603.xml · nonDerivative · entry 1

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,053

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048593-26-000006 · form4-06032026_060601.xml · nonDerivative · entry 1

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,937

F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F2 · price: The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048466-26-000003 · form4-05262026_060522.xml · nonDerivative · entry 3

Lezack Adam · CIK 0002048466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,399

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.

SEC source: 0001810701-26-000003 · form4-05262026_060528.xml · nonDerivative · entry 1

Palasis Maria · CIK 0001810701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,397

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

SEC source: 0001235644-26-000008 · form4-05262026_060533.xml · nonDerivative · entry 1

MICHEL GERARD J · CIK 0001235644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,509

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

SEC source: 0002048467-26-000003 · form4-05262026_060530.xml · nonDerivative · entry 2

Jones Christy · CIK 0002048467 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,211

F2 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

SEC source: 0002048467-26-000003 · form4-05262026_060530.xml · nonDerivative · entry 1

Jones Christy · CIK 0002048467 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,246

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.

SEC source: 0001756438-26-000003 · form4-05262026_060527.xml · nonDerivative · entry 1

Dearen Danny L. · CIK 0001756438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,209

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

SEC source: 0001239312-26-000003 · form4-05262026_060524.xml · nonDerivative · entry 1

CARNEY SEAN · CIK 0001239312 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,209

F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

SEC source: 0002048466-26-000003 · form4-05262026_060522.xml · nonDerivative · entry 2

Lezack Adam · CIK 0002048466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,397

F2 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

SEC source: 0002048466-26-000003 · form4-05262026_060522.xml · nonDerivative · entry 1

Lezack Adam · CIK 0002048466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,432

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.

SEC source: 0002048497-26-000002 · form4-03062026_120301.xml · nonDerivative · entry 1

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,133

F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.

SEC source: 0002051384-26-000001 · form4-03032026_060308.xml · nonDerivative · entry 2

Russell Steven Jon · CIK 0002051384 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,096

F2 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F3 · price: The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048497-26-000001 · form4-03032026_060310.xml · nonDerivative · entry 2

Hopman Mark · CIK 0002048497 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,486

F2 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F3 · price: The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048500-26-000004 · form4-03032026_060306.xml · nonDerivative · entry 2

Mensinger Mike · CIK 0002048500 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,793

F2 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F3 · price: The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048588-26-000003 · form4-03032026_060304.xml · nonDerivative · entry 2

Feider Stephen · CIK 0002048588 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,729

F2 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F3 · price: The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002048593-26-000001 · form4-03032026_060302.xml · nonDerivative · entry 2

Saint Sean · CIK 0002048593 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 437,809

F2 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

F3 · price: The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

SEC source: 0002051384-26-000001 · form4-03032026_060308.xml · derivative · entry 3

Russell Steven Jon · CIK 0002051384 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,749

Underlying: Common Stock · 58,749 shares

Expires 2036-02-26

F4 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026.